17 results
8-K
EX-99.1
COYA
Coya Therapeutics Inc
19 Mar 24
Coya Therapeutics Provides a Corporate Update and Reports Fiscal 2023 Financial Results
8:21am
offset by a $1.4 million decrease in costs attributable to our sponsored research agreement with Houston Methodist Hospital and a $0.3 million decrease
8-K
EX-99.1
id30b1pd3wec2n
8 Aug 23
Coya Therapeutics, Inc. Provides Business Update and Reports Q2 2023 Unaudited Financial Results
7:05am
10-Q
lg3 byzv39hcbky
10 May 23
Quarterly report
7:14am
10-K
8w1jyj6ym40ozjhd03df
29 Mar 23
Annual report
4:08pm
424B4
cvdvog9b3yro7r1i whe
30 Dec 22
Prospectus supplement with pricing info
4:17pm
S-1/A
EX-10.1
l1mhsloxoijx2z3
5 Dec 22
IPO registration (amended)
8:16am
S-1/A
hxoit1m9 xc5b41z
5 Dec 22
IPO registration (amended)
8:16am
S-1
pu1tjfl udvlmdtnyt
18 Nov 22
IPO registration
5:06pm
DRS/A
l9tavmqhi30c9uvo
28 Oct 22
Draft registration statement (amended)
12:00am
DRS/A
8nlt3
7 Oct 22
Draft registration statement (amended)
12:00am
DRS
dzg 09fngxie9ibkva
19 Aug 22
Draft registration statement
12:00am
- Prev
- 1
- Next